ZNF18

Across TCGA pan-cancer cohorts, ZNF18 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZNF18 data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher ZNF18 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF18 expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.

PDAC and GBM are the cancer types where ZNF18 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Quartile	II,III,IV	1.000	0.730	.011	22	view →
GBM	OS	Median	All	0.165	0.740	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ZNF18–PDAC (DFS)

Open the PDAC breakdown →